These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological significance of the species differences in bupropion metabolism. Welch RM; Lai AA; Schroeder DH Xenobiotica; 1987 Mar; 17(3):287-98. PubMed ID: 3107223 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of bupropion: a review. Lai AA; Schroeder DH J Clin Psychiatry; 1983 May; 44(5 Pt 2):82-4. PubMed ID: 6406470 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay and pharmacokinetic profile of bupropion in the dog. Butz RF; Schroeder DH; Welch RM; Mehta NB; Phillips AP; Findlay JW J Pharmacol Exp Ther; 1981 Jun; 217(3):602-10. PubMed ID: 6785419 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Suckow RF; Smith TM; Perumal AS; Cooper TB Drug Metab Dispos; 1986; 14(6):692-7. PubMed ID: 2877828 [TBL] [Abstract][Full Text] [Related]
6. Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice. Butz RF; Welch RM; Findlay JW J Pharmacol Exp Ther; 1982 Jun; 221(3):676-85. PubMed ID: 6806465 [No Abstract] [Full Text] [Related]
8. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
9. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
10. The effect of H2-antagonists on the absorption of bupropion in rats. al-Khamis KI; Kaka JS; Tanira MO Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):279-82. PubMed ID: 2895943 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Findlay JW; Van Wyck Fleet J; Smith PG; Butz RF; Hinton ML; Blum MR; Schroeder DH Eur J Clin Pharmacol; 1981; 21(2):127-35. PubMed ID: 6804243 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma. Steinke W; Ahr HJ; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280 [TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
15. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans. Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038 [TBL] [Abstract][Full Text] [Related]
16. The disposition of acyclovir in different species. de Miranda P; Krasny HC; Page DA; Elion GB J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622 [TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of zopiclone. Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549 [TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]